Scientific Reports · 2018 · 25 citations · 13 references
MedicineMolecular PharmaceuticsPharmacologyDiagnostic ImagingDrug DeliveryMolecular ImagingMagnetic Resonance Contrast MechanismsMagnetic Resonance ImagingMagnetic Resonance Molecular ImagingMagnetic Resonance SpectroscopyMolecular Probe DevelopmentTargeted Imaging AgentsChemical Shift ImagingFluorine-18 RadiopharmaceuticalsFluorine-19 Magnetic Resonance ImagingLiposomal NanocarriersMolecular Imaging TracersMolecular Target ImagingNuclear Magnetic Resonance QuantificationStability Of Liposomal Formulations
Abstract Fluorine-19 ( 19 F) Magnetic Resonance Imaging (MRI) is an emerging modality for molecular imaging and cell tracking. The hydrophobicity of current exogenous probes, perfluorocarbons (PFCs) and perfluoropolyethers (PFPEs), limits the formulation options available for in vivo applications. Hydrophilic probes permit more formulation flexibility. Further, the broad Nuclear Magnetic Resonance (NMR) chemical shift range of organofluorine species enables multiple probes with unique 19 F MR signatures for simultaneous interrogation of distinct molecular targets in vivo . We report herein a flexible approach to stable liposomal formulations of hydrophilic fluorinated molecules (each bearing numerous magnetically equivalent 19 F atoms), with 19 F encapsulation of up to 22.7 mg/mL and a per particle load of 3.6 × 10 6 19 F atoms. Using a combination of such probes, we demonstrate, with no chemical shift artifacts, the simultaneous imaging of multiple targets within a given target volume by spectral 19 F MRI.
13
Fluorine (<sup>19</sup>F) MRS and MRI in biomedicine
Jesús Ruı́z-Cabello, Brad P. Barnett, Paul A. Bottomley et al. · NMR in Biomedicine · 2010 · 478 citations · Full text